Skip to content

Somapacitan

SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

Also known as: NN8640, NNC0195-0092, sogroya, somapacitan (genetical recombination), somapacitan-beco

EMA approvedFDA approvedPMDA approvedATC H01AC07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Somapacitan is a drug catalogued in DrugCentral. It was first approved by the FDA in 2020. DrugCentral lists 1 molecular target, including GHR. Recorded indications include Adult growth hormone deficiency.

  • Molecular targets: GHR (1 listed in DrugCentral).
  • Indications: Adult growth hormone deficiency.
  • ATC code: H01AC07 (Somatropin and somatropin agonists).

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Adult growth hormone deficiency

Contraindications (2)

  • Diabetic retinopathy
  • Malignant neoplastic disease

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Growth hormone receptorGHRunknownKd 8.04

Regulatory approvals (3)

DateAgencyMarketed asApplicantOrphan
2023-06-26PMDA—Novo Nordisk Pharma Ltd.
2021-03-31EMA—Novo Nordisk A/S
2020-08-28FDA—NOVO NORDISK INC

ATC classification

ATC codeTherapeutic hierarchy
H01AC07SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS › PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES › ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES › Somatropin and somatropin agonists

Chemical structure

Molecular formula—
Molecular weight—
CAS number1338578-34-9
InChIKey—
PubChem CID129894493

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Somapacitan used for?

DrugCentral lists the following indications for Somapacitan: Adult growth hormone deficiency.

How does Somapacitan work?

Its molecular targets in DrugCentral include GHR.

When was Somapacitan first approved?

Somapacitan was first approved by the FDA in 2020.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2020-08-28
AgencyFDA
Targets1
Indications1
Formula—
DrugCentral ID5413
Interactive profile